Bearing Point Capital, LLC Gilead Sciences, Inc. Transaction History
Bearing Point Capital, LLC
- $470 Billion
- Q1 2025
A detailed history of Bearing Point Capital, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bearing Point Capital, LLC holds 4,300 shares of GILD stock, worth $431,462. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,300
Previous 6,370
32.5%
Holding current value
$431,462
Previous $588 Million
18.11%
% of portfolio
0.1%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,247Shares Held
998MCall Options Held
8.86MPut Options Held
8.69M-
Black Rock Inc. New York, NY121MShares$12.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$11.8 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$5.97 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.48 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.37 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $126B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...